These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 19185908)
21. Improved prostate cancer treatment. Health News; 2002 Sep; 8(9):8. PubMed ID: 12229905 [No Abstract] [Full Text] [Related]
22. [Interest of the radiotherapy-hormonotherapy association in the treatment of the high-risk prostate cancer]. Bolla M; Fourneret P; Descotes JL Bull Cancer; 2008 Dec; 95(12):1213-8. PubMed ID: 19091656 [TBL] [Abstract][Full Text] [Related]
24. Total androgen suppression in the management of prostatic cancer. A critical review. Schroeder FH Prog Clin Biol Res; 1985; 185A():307-17. PubMed ID: 3898133 [No Abstract] [Full Text] [Related]
25. [Principles for the conservative drug therapy treatment of prostate cancer]. Hofmann W Z Urol Nephrol; 1981 Sep; 74(9):697-704. PubMed ID: 7314992 [No Abstract] [Full Text] [Related]
26. Toward the optimal use of androgen suppression therapy in the radiotherapeutic management of prostate cancer. D'Amico AV J Clin Oncol; 2007 Jan; 25(1):8-9. PubMed ID: 17194901 [No Abstract] [Full Text] [Related]
27. [Proton hypophysectomy and subtotal body irradiation in combined treatment of stage IV prostate cancer]. Aleksandrov VP; Kondrat'eva EA; Karelin MI; Konnov BA; Zharinov GM; Metelev VV; Pecherskiĭ AV Urologiia; 1999; (6):26-8. PubMed ID: 16859000 [No Abstract] [Full Text] [Related]
28. Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy. Chen RC; Sadetsky N; Chen MH; Carroll PR; D'Amico AV Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):36-9. PubMed ID: 19233568 [TBL] [Abstract][Full Text] [Related]
30. Managing hot flashes in men being treated for prostate cancer. Baum NH; Torti DC Geriatrics; 2007 Nov; 62(11):18-21. PubMed ID: 17999566 [TBL] [Abstract][Full Text] [Related]
31. Chemical castration and survival in low-risk prostate cancer. van der Poel HG Eur Urol; 2009 Oct; 56(4):617-8. PubMed ID: 19349109 [No Abstract] [Full Text] [Related]
32. Management of castration-resistant prostate cancer: a call to urologists. Fitzpatrick JM BJU Int; 2012 Sep; 110(6):772-4. PubMed ID: 22882501 [No Abstract] [Full Text] [Related]
33. Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer. Moul JW Cancer; 2009 Aug; 115(15):3376-8. PubMed ID: 19484788 [No Abstract] [Full Text] [Related]
40. Editorial comment on: new treatment approaches for prostate cancer based on peptide analogues. Bamias A; Dimopoulos MA Eur Urol; 2008 May; 53(5):899-900. PubMed ID: 18201817 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]